Pyc Therapeutics Ltd has released a press release.
Review of Activities and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Successful Institutional Entitlement Offer and Placement
- PYC Business and Equity Raising Presentation
- PYC Equity Raising to Raise up to $55 Million
- New Drug for Substantial Unmet Need Added to Pipeline
- PYCs Lead Drug Effective in Patient Derived Models Tested
Later from PYC Therapeutics
- Visual Evidence of Lead Drugs Efficacy
- Quarterly Activities Report and Appendix 4C
- Progress US Clinical Stage Company and Corporate Objectives
- Half Year Accounts and Appendix 4D
- Lead Investigational Drug Demonstrates Key Improvement
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics